Paul Tudor Jones Sc Pharmaceuticals Inc. Transaction History
Tudor Investment Corp Et Al
- $200 Billion
- Q3 2025
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Sc Pharmaceuticals Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 2,150,000 shares of SCPH stock, worth $12.2 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,150,000Holding current value
$12.2 Million% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding SCPH
# of Institutions
117Shares Held
40.5MCall Options Held
835KPut Options Held
11.9K-
Orbimed Advisors LLC San Diego, CA6.06MShares$34.4 Million1.17% of portfolio
-
Rubric Capital Management LP New York, NY5.1MShares$28.9 Million0.47% of portfolio
-
Weiss Asset Management LP Boston, MA2.88MShares$16.3 Million0.31% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.18MShares$12.3 Million0.0% of portfolio
-
King Luther Capital Management Corp Fort Worth, TX2.13MShares$12.1 Million0.05% of portfolio
About scPharmaceuticals Inc.
- Ticker SCPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,402,100
- Market Cap $155M
- Description
- scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product p...